Trademark: 88758472
Word
RAVERUS THERAPEUTICS
Status Date
Monday, February 8, 2021
Filing Date
Tuesday, January 14, 2020
Published for Opposition
Tuesday, May 12, 2020
Abandoned Date
Monday, February 8, 2021
5 pharmaceutical preparations for the prevention of liver diseases and disorders; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the prevention of kidney diseases and disorders; pharmaceutical preparations for the treatment of kidney diseases and disorders; pharmaceutical preparations for the prevention of central nervous system diseases and disorders; pharmaceutical preparations for the treatment of central nervous system diseases and disorders; pharmaceutical preparations for the prevention of monogenic diseases and disorders; pharmaceutical preparations for the treatment of monogenic diseases and disorders; pharmaceutical preparations for the prevention of metabolic diseases and disorders; pharmaceutical preparations for the treatment of metabolic diseases and disorders; therapeutic preparations for the prevention of liver diseases and disorders; therapeutic preparations for the treatment of liver diseases and disorders; therapeutic preparations for the prevention of kidney diseases and disorders; therapeutic preparations for the treatment of kidney diseases and disorders; therapeutic preparations for the prevention of central nervous system diseases and disorders; therapeutic preparations for the treatment of central nervous system diseases and disorders; therapeutic preparations for the prevention of monogenic diseases and disorders; therapeutic preparations for the treatment of monogenic diseases and disorders; therapeutic preparations for the prevention of metabolic diseases and disorders; therapeutic preparations for the treatment of metabolic diseases and disorders
42 Research and development of pharmaceuticals for the treatment of rare diseases; medical research
44 Providing health and medical information; providing a website featuring health and medical information
Feb 8, 2021
Abandonment Notice E-Mailed - No Use Statement Filed
Feb 8, 2021
Abandonment - No Use Statement Filed
Jul 7, 2020
Noa E-Mailed - Sou Required From Applicant
May 12, 2020
Official Gazette Publication Confirmation E-Mailed
May 12, 2020
Published For Opposition
Apr 22, 2020
Notification Of Notice Of Publication E-Mailed
Apr 2, 2020
Assigned To Lie
Mar 24, 2020
Approved For Pub - Principal Register
Mar 23, 2020
Examiner's Amendment Entered
Mar 23, 2020
Notification Of Examiners Amendment E-Mailed
Mar 23, 2020
Examiners Amendment E-Mailed
Mar 23, 2020
Examiners Amendment -Written
Mar 11, 2020
Teas/Email Correspondence Entered
Mar 11, 2020
Correspondence Received In Law Office
Mar 11, 2020
Teas Response To Office Action Received
Feb 10, 2020
Notification Of Non-Final Action E-Mailed
Feb 10, 2020
Non-Final Action E-Mailed
Feb 10, 2020
Non-Final Action Written
Feb 5, 2020
Assigned To Examiner
Jan 18, 2020
New Application Office Supplied Data Entered In Tram
Jan 17, 2020
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
